Lu Hongbo's Form 4 filing
Arrowhead Pharmaceuticals, Inc. (ARWR) · filed Mar 20, 2024
- Accession no.
- 0001628280-24-012327
- Filed
- Mar 20, 2024
- Trade date
- Mar 18-20, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $83.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lu HongboCIK 0001767584 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 18, 2024 | Common Stock | PPurchaseAcquired | +1,000 | $27.49 | +$27,490 | 31,680 | Direct | |
| Mar 19, 2024 | Common Stock | PPurchaseAcquired | +1,000 | $28.00 | +$28,000 | 32,680 | Direct | |
| Mar 20, 2024 | Common Stock | PPurchaseAcquired | +1,000 | $27.50 | +$27,500 | 33,680 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.